AAAAAA
Results: 1-25/39
Authors:
Ascioglu, S
Rex, JH
de Pauw, B
Bennett, JE
Bille, J
Crokaert, F
Denning, DW
Donnelly, JP
Edwards, JE
Erjavec, Z
Fiere, D
Lortholary, O
Maertens, J
Meis, JF
Patterson, TF
Ritter, J
Selleslag, D
Shah, PM
Stevens, DA
Walsh, TJ
Citation: S. Ascioglu et al., Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An internationalconsensus, CLIN INF D, 34(1), 2002, pp. 7-14
Authors:
Denning, DW
Citation: Dw. Denning, Chronic forms of pulmonary aspergillosis, CL MICRO IN, 7, 2001, pp. 25-31
Authors:
Denning, DW
Munoz, P
Citation: Dw. Denning et P. Munoz, Advances in invasive fungal infection and antifungal therapy: Introduction, CL MICRO IN, 7, 2001, pp. VII-VII
Authors:
Moore, CB
Oakley, KL
Denning, DW
Citation: Cb. Moore et al., In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species, CL MICRO IN, 7(1), 2001, pp. 11-16
Authors:
Rex, JH
Walsh, TJ
Nettleman, M
Anaissie, EJ
Bennett, JE
Bow, EJ
Carillo-Munoz, AJ
Chavanet, P
Cloud, GA
Denning, DW
de Pauw, BE
Edwards, JE
Hiemenz, JW
Kauffman, CA
Lopez-Berestein, G
Martino, P
Sobel, JD
Stevens, DA
Sylvester, R
Tollemar, J
Viscoli, C
Viviani, MA
Wu, T
Citation: Jh. Rex et al., Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses, CLIN INF D, 33(1), 2001, pp. 95-106
Authors:
Denning, DW
Citation: Dw. Denning, Invasive aspergillosis in cancer patients - The Bow article reviewed, ONCOLOGY-NY, 15(8), 2001, pp. 1040
Authors:
Riddell, LA
Pinching, AJ
Hill, S
Ng, TT
Arbe, E
Lapham, GP
Ash, S
Hillman, R
Tchamouroff, S
Denning, DW
Parkin, JM
Citation: La. Riddell et al., A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease, AIDS RES H, 17(9), 2001, pp. 789-797
Authors:
Heald, AH
O'Halloran, DJ
Richards, K
Webb, F
Jenkins, S
Hollis, S
Denning, DW
Young, RJ
Citation: Ah. Heald et al., Fungal infection of the diabetic foot: two distinct syndromes, DIABET MED, 18(7), 2001, pp. 567-572
Authors:
Caillot, D
Couaillier, JF
Bernard, A
Casasnovas, O
Denning, DW
Mannone, L
Lopez, J
Couillault, G
Piard, F
Vagner, O
Guy, H
Citation: D. Caillot et al., Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia, J CL ONCOL, 19(1), 2001, pp. 253-259
Authors:
Denning, DW
Griffiths, CEM
Citation: Dw. Denning et Cem. Griffiths, Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole, CLIN EXP D, 26(8), 2001, pp. 648-653
Authors:
Mosquera, J
Warn, PA
Rodriguez-Tudela, JL
Denning, DW
Citation: J. Mosquera et al., Treatment of Absidia corymbifera infection in mice with amphotericin B anditraconazole, J ANTIMICRO, 48(4), 2001, pp. 583-586
Authors:
Williams, KJ
Denning, DW
Citation: Kj. Williams et Dw. Denning, Termination of development of D0870 - J Antimicrob Chemother 2001; 47: 720-721, J ANTIMICRO, 47(5), 2001, pp. 720-721
Authors:
Wenisch, C
Moore, CB
Krause, R
Presterl, E
Pichna, P
Denning, DW
Citation: C. Wenisch et al., Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome, J CLIN MICR, 39(7), 2001, pp. 2458-2462
Authors:
Moore, CB
Walls, CM
Denning, DW
Citation: Cb. Moore et al., In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B, ANTIM AG CH, 45(6), 2001, pp. 1882-1885
Authors:
Mosquera, J
Warn, PA
Morrissey, J
Moore, CB
Gil-Lamaignere, C
Denning, DW
Citation: J. Mosquera et al., Susceptibility testing of Aspergillus flavus: Inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo, ANTIM AG CH, 45(5), 2001, pp. 1456-1462
Authors:
Crosdale, DJ
Poulton, KV
Ollier, WE
Thomson, W
Denning, DW
Citation: Dj. Crosdale et al., Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis, J INFEC DIS, 184(5), 2001, pp. 653-656
Authors:
Brookman, JL
Denning, DW
Citation: Jl. Brookman et Dw. Denning, Molecular genetics in Aspergillus fumigatus, CURR OPIN M, 3(5), 2000, pp. 468-474
Authors:
Stevens, DA
Kan, VL
Judson, MA
Morrison, VA
Dummer, S
Denning, DW
Bennett, JE
Walsh, TJ
Patterson, TF
Pankey, GA
Citation: Da. Stevens et al., Practice guidelines for diseases caused by Aspergillus, CLIN INF D, 30(4), 2000, pp. 696-709
Authors:
Lortholary, O
Ascioglu, S
Moreau, P
Herbrecht, R
Marinus, A
Casassus, P
De Pauw, B
Denning, DW
Citation: O. Lortholary et al., Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: A European organization for research and treatment of cancer, CLIN INF D, 30(1), 2000, pp. 41-46
Authors:
Thuraisingam, AI
Denning, DW
Citation: Ai. Thuraisingam et Dw. Denning, Candida glabrata oesophagitis in a patient without HIV infection, EUR J CL M, 19(7), 2000, pp. 561-562
Authors:
Ng, A
Gadong, N
Kelsey, A
Denning, DW
Leggate, J
Eden, OB
Citation: A. Ng et al., Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia, PED HEM ONC, 17(6), 2000, pp. 497-504
Authors:
Johnson, EM
Oakley, KL
Radford, SA
Moore, CB
Warn, P
Warnock, DW
Denning, DW
Citation: Em. Johnson et al., Lack of correlation of in vitro amphotericin B susceptibility testing withoutcome in a murine model of Aspergillus infection, J ANTIMICRO, 45(1), 2000, pp. 85-93
Authors:
Moore, CB
Sayers, N
Mosquera, J
Slaven, J
Denning, DW
Citation: Cb. Moore et al., Antifungal drug resistance in Aspergillus, J INFECTION, 41(3), 2000, pp. 203-220
Authors:
Denning, DW
Citation: Dw. Denning, Early diagnosis of invasive aspergillosis - Author's reply, LANCET, 355(9220), 2000, pp. 2076-2076
Authors:
Denning, DW
Citation: Dw. Denning, Early diagnosis of invasive aspergillosis, LANCET, 355(9202), 2000, pp. 423-424